Therefore, we derived CD19-CAR-T cells from PBMCs of CLL patients (referred to as CLL-CAR-T cells) and investigated the role of ITK in CLL-CAR-T cells. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.